Skip to content
Search

Latest Stories

NHS England staff to get 3 per cent pay rise

NHS England staff, who have been on the frontlines of the battle against the coronavirus pandemic, will receive a 3 per cent pay rise, the government said on Wednesday (July 21).

The pay rise for staff including nurses, paramedics, consultants, dentists and salaried general practitioners (GPs) will be backdated to April 2021.


It was immediately criticised by unions, who called it insulting.

The government had initially offered a 1 per cent pay rise, drawing an angry response from staff, unions and the general public who said it was scant reward for their work during the pandemic, which is still raging in the United Kingdom.

"NHS staff are rightly receiving a pay rise this year despite the wider public sector pay pause, in recognition of their extraordinary efforts," health minister Sajid Javid said.

The government made an improved offer after it accepted the recommendations of independent pay review bodies.

For the average nurse, the rise will mean an additional £1,000 a year, while many porters and cleaners will receive around £540 pounds more, the government said.

However, nurses' union the Royal College of Nursing said the rise amounted to a pay cut when inflation is taken into account.

"When the Treasury expects inflation to be 3.7 per cent, ministers are knowingly cutting pay for an experienced nurse by over 200 pounds in real-terms," said the union's general secretary and chief executive Pat Cullen.

She said members will be consulted on what action they would take next.

The GMB union, which represents health workers including ambulance workers, called the rise "paltry" and "insulting".

The rise for NHS staff in England falls short of the 4 per cent increase backdated to December 2020 given by the Scottish government to NHS Scotland staff.

Health spending and public sector pay is a responsibility of the devolved nations in the United Kingdom – Scotland, Wales and Northern Ireland.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less